1.70
price up icon0.59%   0.01
after-market Handel nachbörslich: 1.70
loading
Schlusskurs vom Vortag:
$1.69
Offen:
$1.68
24-Stunden-Volumen:
1.85M
Relative Volume:
1.72
Marktkapitalisierung:
$188.40M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-3.3465
EPS:
-0.508
Netto-Cashflow:
$703.00K
1W Leistung:
+6.92%
1M Leistung:
+27.82%
6M Leistung:
-52.65%
1J Leistung:
-54.91%
1-Tages-Spanne:
Value
$1.655
$1.72
1-Wochen-Bereich:
Value
$1.555
$1.725
52-Wochen-Spanne:
Value
$1.22
$4.96

Omniab Inc Stock (OABI) Company Profile

Name
Firmenname
Omniab Inc
Name
Telefon
510-250-7800
Name
Adresse
5980 HORTON STREET, EMERYVILLE
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
OABI's Discussions on Twitter

Vergleichen Sie OABI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OABI
Omniab Inc
1.70 188.40M 34.16M -50.62M 703.00K -0.508
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Omniab Inc Stock (OABI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-04-21 Eingeleitet The Benchmark Company Buy
2023-04-13 Eingeleitet Craig Hallum Buy
2023-02-22 Eingeleitet Cowen Outperform
2023-02-13 Eingeleitet H.C. Wainwright Buy
2022-12-20 Eingeleitet Truist Buy
2022-12-16 Eingeleitet Credit Suisse Outperform
2022-11-29 Eingeleitet SVB Leerink Outperform
2022-11-28 Eingeleitet Stifel Buy
Alle ansehen

Omniab Inc Aktie (OABI) Neueste Nachrichten

pulisher
Jun 18, 2025

OmniAb Elects Directors at Annual Shareholder Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

OmniAb shareholders elect two directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 11, 2025

OmniAb Inc Inc. (OABI) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Jun 11, 2025
pulisher
Jun 09, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Buys 61,993 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

June 2025's Promising Penny Stocks to Consider - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

OmniAb, Inc. (NASDAQ:OABI) Stake Cut by Jane Street Group LLC - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

AI Is Rewiring Healthcare Faster Than Expected — Investors Are Hunting for Public Winners Now - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.025 per Common Limited Partner Unit - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Purchased by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Buys Shares of 17,549 OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Bank of America Corp DE Has $2.18 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jun 03, 2025
pulisher
May 30, 2025

OABI stock touches 52-week low at $1.25 amid market challenges - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

OABI stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 24, 2025

Northern Trust Corp Acquires 45,169 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 24, 2025
pulisher
May 23, 2025

Deutsche Bank AG Increases Stake in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 23, 2025
pulisher
May 23, 2025

Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass - insights.citeline.com

May 23, 2025
pulisher
May 20, 2025

OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada

May 20, 2025
pulisher
May 19, 2025

OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister

May 19, 2025
pulisher
May 19, 2025

Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st

May 19, 2025
pulisher
May 19, 2025

Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 18, 2025
pulisher
May 17, 2025

Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Director Makes Bold Move with Major OmniAb Stock Purchase - TipRanks

May 15, 2025
pulisher
May 15, 2025

Insider Buying: Steven Love Acquires 25,000 Shares of OmniAb Inc (OABI) - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Director’s Bold Move: A Major Investment in OmniAb Stock - TipRanks

May 14, 2025
pulisher
May 14, 2025

Insider Buying: John Higgins Acquires 65,000 Shares of OmniAb In - GuruFocus

May 14, 2025
pulisher
May 13, 2025

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Makes New Investment in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 13, 2025
pulisher
May 13, 2025

OmniAb’s (OABI) “Buy” Rating Reaffirmed at Benchmark - Defense World

May 13, 2025
pulisher
May 12, 2025

OmniAb: Too Much Risk, Not Enough Reward (NASDAQ:OABI) - Seeking Alpha

May 12, 2025
pulisher
May 11, 2025

OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript - MSN

May 11, 2025
pulisher
May 11, 2025

OmniAb : May 2025 Corporate Overview - marketscreener.com

May 11, 2025
pulisher
May 11, 2025

Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88 - simplywall.st

May 11, 2025
pulisher
May 11, 2025

Dimensional Fund Advisors LP Increases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World

May 11, 2025
pulisher
May 10, 2025

RBC Capital Remains a Buy on OmniAb (OABI) - The Globe and Mail

May 10, 2025
pulisher
May 09, 2025

OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks

May 09, 2025
pulisher
May 09, 2025

OmniAb Introduces the xPloration® Partner Access Program - BioSpace

May 09, 2025
pulisher
May 09, 2025

OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls By Investing.com - Investing.com South Africa

May 09, 2025
pulisher
May 09, 2025

Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

OmniAb Introduces the xPloration(R) Partner Access Program - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

OmniAb Reports Steady Growth in Q1 2025 - TipRanks

May 09, 2025

Finanzdaten der Omniab Inc-Aktie (OABI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Omniab Inc-Aktie (OABI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Love Steven
Director
May 14 '25
Buy
1.46
25,000
36,500
38,333
HIGGINS JOHN L
Director
May 12 '25
Buy
1.44
65,000
93,600
2,831,887
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Option Exercise
0.00
36,458
0
3,815,618
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Sale
2.00
19,382
38,764
3,796,236
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Option Exercise
0.00
13,542
0
370,418
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Sale
2.00
7,206
14,412
363,212
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Option Exercise
0.00
13,542
0
231,034
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Sale
2.00
7,206
14,412
223,828
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):